178 related articles for article (PubMed ID: 23268342)
1. Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced.
Ishii T; Fukuta T; Agato Y; Oyama D; Yasuda N; Shimizu K; Kawaguchi AT; Asai T; Oku N
Biochem Biophys Res Commun; 2013 Jan; 430(4):1201-5. PubMed ID: 23268342
[TBL] [Abstract][Full Text] [Related]
2. Amelioration of cerebral ischemia-reperfusion injury based on liposomal drug delivery system with asialo-erythropoietin.
Ishii T; Asai T; Oyama D; Fukuta T; Yasuda N; Shimizu K; Minamino T; Oku N
J Control Release; 2012 May; 160(1):81-7. PubMed ID: 22342472
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotection against cerebral ischemia/reperfusion injury by intravenous administration of liposomal fasudil.
Fukuta T; Asai T; Sato A; Namba M; Yanagida Y; Kikuchi T; Koide H; Shimizu K; Oku N
Int J Pharm; 2016 Jun; 506(1-2):129-37. PubMed ID: 27107903
[TBL] [Abstract][Full Text] [Related]
4. Reperfusion-induced temporary appearance of therapeutic window in penumbra after 2 h of photothrombotic middle cerebral artery occlusion in rats.
Yao H; Yoshii N; Akira T; Nakahara T
J Cereb Blood Flow Metab; 2009 Mar; 29(3):565-74. PubMed ID: 19088742
[TBL] [Abstract][Full Text] [Related]
5. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection.
Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC
Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720
[TBL] [Abstract][Full Text] [Related]
6. Treatment of stroke with liposomal neuroprotective agents under cerebral ischemia conditions.
Fukuta T; Ishii T; Asai T; Sato A; Kikuchi T; Shimizu K; Minamino T; Oku N
Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):1-7. PubMed ID: 26455340
[TBL] [Abstract][Full Text] [Related]
7. Treatment of cerebral ischemia-reperfusion injury with PEGylated liposomes encapsulating FK506.
Ishii T; Asai T; Oyama D; Agato Y; Yasuda N; Fukuta T; Shimizu K; Minamino T; Oku N
FASEB J; 2013 Apr; 27(4):1362-70. PubMed ID: 23241312
[TBL] [Abstract][Full Text] [Related]
8. Treatment of rats with pioglitazone in the reperfusion phase of focal cerebral ischemia: a preclinical stroke trial.
Culman J; Nguyen-Ngoc M; Glatz T; Gohlke P; Herdegen T; Zhao Y
Exp Neurol; 2012 Dec; 238(2):243-53. PubMed ID: 22995601
[TBL] [Abstract][Full Text] [Related]
9. Real-time trafficking of PEGylated liposomes in the rodent focal brain ischemia analyzed by positron emission tomography.
Fukuta T; Ishii T; Asai T; Nakamura G; Takeuchi Y; Sato A; Agato Y; Shimizu K; Akai S; Fukumoto D; Harada N; Tsukada H; Kawaguchi AT; Oku N
Artif Organs; 2014 Aug; 38(8):662-6. PubMed ID: 25295359
[TBL] [Abstract][Full Text] [Related]
10. [Effects of aromatic resuscitation drugs on blood brain barrier in cerebral ischemia-reperfusion injury model rats].
Ni C; Zeng N; Xu F; Gou L; Liu J; Wang J; Xia H
Zhongguo Zhong Yao Za Zhi; 2011 Sep; 36(18):2562-6. PubMed ID: 22256767
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial function and cerebral blood flow variable responses to middle cerebral artery occlusion.
Livnat A; Barbiro-Michaely E; Mayevsky A
J Neurosci Methods; 2010 Apr; 188(1):76-82. PubMed ID: 20109493
[TBL] [Abstract][Full Text] [Related]
12. A single injection of liposomal asialo-erythropoietin improves motor function deficit caused by cerebral ischemia/reperfusion.
Ishii T; Asai T; Fukuta T; Oyama D; Yasuda N; Agato Y; Shimizu K; Minamino T; Oku N
Int J Pharm; 2012 Dec; 439(1-2):269-74. PubMed ID: 22989979
[TBL] [Abstract][Full Text] [Related]
13. [Application of diffusion-weighted and perfusion magnetic resonance imaging in definition of the ischemic penumbra in hyperacute cerebral infarction].
Feng XY; Liang J; Yin XD; Han X; Dong Q; Lü CZ
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):952-7. PubMed ID: 12899795
[TBL] [Abstract][Full Text] [Related]
14. Role of activating transcription factor 3 in ischemic penumbra region following transient middle cerebral artery occlusion and reperfusion injury.
Song DY; Oh KM; Yu HN; Park CR; Woo RS; Jung SS; Baik TK
Neurosci Res; 2011 Aug; 70(4):428-34. PubMed ID: 21616101
[TBL] [Abstract][Full Text] [Related]
15. Dynamic expression of glucose transporters 1 and 3 in the brain of diabetic rats with cerebral ischemia reperfusion.
Zhang WW; Zhang L; Hou WK; Xu YX; Xu H; Lou FC; Zhang Y; Wang Q
Chin Med J (Engl); 2009 Sep; 122(17):1996-2001. PubMed ID: 19781384
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of signal transducer and activator of transcription-3 (Stat3) after focal cerebral ischemia in rats.
Suzuki S; Tanaka K; Nogawa S; Dembo T; Kosakai A; Fukuuchi Y
Exp Neurol; 2001 Jul; 170(1):63-71. PubMed ID: 11421584
[TBL] [Abstract][Full Text] [Related]
17. Oxyresveratrol (trans-2,3',4,5'-tetrahydroxystilbene) is neuroprotective and inhibits the apoptotic cell death in transient cerebral ischemia.
Andrabi SA; Spina MG; Lorenz P; Ebmeyer U; Wolf G; Horn TF
Brain Res; 2004 Aug; 1017(1-2):98-107. PubMed ID: 15261105
[TBL] [Abstract][Full Text] [Related]
18. Altered plasma and brain disposition of isopropylidene shikimic acid liposome in rats and the brain protection in cerebral ischemia-reperfusion.
Qu C; Ni J; Yang P; Zhang H; Lin L; Li J; Tian J; Fu J; Yin X; Kong H
Drug Dev Ind Pharm; 2013 Sep; 39(9):1291-5. PubMed ID: 23020069
[TBL] [Abstract][Full Text] [Related]
19. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke.
Miller AA; Dusting GJ; Roulston CL; Sobey CG
Brain Res; 2006 Sep; 1111(1):111-6. PubMed ID: 16879806
[TBL] [Abstract][Full Text] [Related]
20. Neuroprotective effects of VEGF administration after focal cerebral ischemia/reperfusion: dose response and time window.
Yang J; Guo L; Liu R; Liu H
Neurochem Int; 2012 May; 60(6):592-6. PubMed ID: 22394692
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
